Assessing Corcept Therapeutics: Insights From 9 Financial Analysts
Trade Deficit Widens to a Record $140.5 Billion
BorgWarner Extends Four Exhaust Gas Recirculation Contracts With North American OEM; Financial Terms Not Disclosed
US Morning News Call | India Proposes Zero-For-Zero Tariffs On Steel, Auto Parts
Corcept Therapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Sales Results. Also, HC Wainwright Maintained a Buy Rating on the Stock but Lowered Its Price Target From $150 to $145.
HC Wainwright & Co. Maintains Buy on Corcept Therapeutics, Lowers Price Target to $145
Corcept Therapeutics Analyst Ratings
Earnings Call Summary | Corcept Therapeutics(CORT.US) Q1 2025 Earnings Conference
Deutsche Bank: The sell-off of USA Assets has been excessive.
Deutsche Bank pointed out that at the beginning of April, the USA market experienced significant volatility, but the panic regarding the dollar, USA Consumer data, and overall confidence in USA Assets may be exaggerated. From a relative valuation perspective, some cyclical USA Consumer stocks may begin to show investment attractiveness. Although policy volatility may persist, the narrative of "selling dollar Assets" may have reached its peak.
Wall Street Futures Dip On Trump's New Tariffs, Fed Meeting In Spotlight
U.S. stocks closed: The three major Indexes all fell, with Berkshire dropping over 5%.
① Apple issued bonds for the first time in two years; ② The Board of Directors of Berkshire Hathaway voted to appoint Abel as CEO, while Buffett continues as Chairman; ③ The reorganization plan of OpenAI had to change and will continue to be controlled by a nonprofit entity.
12 Health Care Stocks Moving In Monday's After-Market Session
Corcept Therapeutics GAAP EPS of $0.17 Beats by $0.03, Revenue of $157.2M Misses by $20.73M
US Morning News Call | Trump Says He Wants a Fair Trade Deal with China
Corcept Therapeutics Q1 2025 Earnings Preview
Earnings Scheduled For May 5, 2025
Tariffs, recession? The U.S. stock market just "doesn't care"!
On one hand, Goldman Sachs believes there is a 45% chance of a recession occurring within the next 12 months, while Apollo recently set it at 90%; on the other hand, the S&P 500 Index has just ended its longest nine-day winning streak since 2004, and bond yields and the dollar have stabilized. However, underlying concerns remain, as investors' risk compensation for U.S. stocks is below historical standards. The market is currently closely monitoring credit card data, which will serve as one of the warning signals.
Earnings Call Summary | SPX Technologies(SPXC.US) Q1 2025 Earnings Conference
IJR ETF Climbs 0.6%
SPX Techs Q1 Adj. EPS $1.38 Misses $1.53 Estimate, Sales $482.60M Miss $544.02M Estimate